POLUZZI, ELISABETTA

POLUZZI, ELISABETTA  

DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Docenti di ruolo di Ia fascia  

Mostra records
Risultati 1 - 20 di 226 (tempo di esecuzione: 0.056 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista Lunghi et al. Drug Safety 2024.pdf40264_2024_1453_MOESM1_ESM.pdf
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E. 2024-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-023-01391-4.pdf40264_2023_1391_MOESM1_ESM.docx
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation Piët J.D.; Booth A.; Donker E.M.; de Ponti F.; Lunghi C.; Poluzzi E.; Janssen B.J.A.; Tun S.Y.M.;... Bekker C.; Dima L.; Costa J.; Jalving M.; Oude Munnink T.H.; van den Bemt P.M.L.A.; Labriffe M.; van Emden T.; van Waardenburg V.; Likic R.; Richir M.; van Agtmael M.A.; Moermond C.T.A.; Tichelaar J. 2024-01-01 THE LANCET. PLANETARY HEALTH - 1.04 Replica / breve intervento (e simili) -
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F. 2024-01-01 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista -
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct Fusaroli M.; Pellegrini L.; Fusaroli R.; Raschi E.; Menchetti M.; Poluzzi E. 2023-01-01 ADDICTION - 1.01 Articolo in rivista Behavioral excess and disruptive conduct A historical and taxonomic approach to the origin of the 'impulse control disorders' diagnostic construct.pdf
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach Giunchi, Valentina; Fusaroli, Michele; Hauben, Manfred; Raschi, Emanuel; Poluzzi, Elisabetta 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista -
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Pont...i F.; Pelotti S.; Poluzzi E. 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista s40264-022-01269-x.pdf40264_2022_1269_MOESM1_ESM.pdf
Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology Noguchi Y.; Yan M.; Yokoyama S.; Poluzzi E. 2023-01-01 FRONTIERS IN PHARMACOLOGY - 1.04 Replica / breve intervento (e simili) fphar-14-1225909.pdf
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study Fusaroli M.; Giunchi V.; Battini V.; Gringeri M.; Rimondini R.; Menchetti M.; Radice S.; Pozzi M....; Nobile M.; Clementi E.; De Ponti F.; Carnovale C.; Raschi E.; Poluzzi E. 2023-01-01 PSYCHIATRY AND CLINICAL NEUROSCIENCES - 1.01 Articolo in rivista Exploring the underlying mechanisms of drug-induced impulse control disorders a pharmacovigilance-pharmacodynamic study.pdf
Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System Fusaroli M.; Simonsen A.; Borrie S.A.; Low D.M.; Parola A.; Raschi E.; Poluzzi E.; Fusaroli R. 2023-01-01 JOURNAL OF SPEECH, LANGUAGE, AND HEARING RESEARCH - 1.01 Articolo in rivista 2022.09.05.22279609v3.full.pdf
Impact of regulatory restrictions on the use of valproic acid in women of childbearing age: An Italian study DiVito L.; Mazzoni S.; Belotti L.M.B.; Poluzzi E.; Baldin E.; Zenesini C.; Bisulli F.; Tinuper P....; Mostacci B. 2023-01-01 EPILEPSIA - 1.01 Articolo in rivista -
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study Fusaroli M.; Salvo F.; Bernardeau C.; Idris M.; Dolladille C.; Pariente A.; Poluzzi E.; Raschi E....; Khouri C. 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista Fusaroli_2023.pdf40264_2023_1329_MOESM2_ESM.xlsx40264_2023_1329_MOESM1_ESM.pdf
Medication use in Italian nursing homes: preliminary results from the national monitoring system Zito S.; Poluzzi E.; Pierantozzi A.; Onder G.; Da Cas R.; Ippoliti I.; Lunghi C.; Cangini A.; Tro...tta F. 2023-01-01 FRONTIERS IN PHARMACOLOGY - 1.01 Articolo in rivista Zito et al. Frontiers in Pharmacology 2023.pdfData Sheet 3.docx
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials Ahmadizar F.; Luxi N.; Raethke M.; Schmikli S.; Riefolo F.; Saraswati P.W.; Bucsa C.; Osman A.; L...iddiard M.; Maques F.B.; Petrelli G.; Sonderlichova S.; Thurin N.H.; Villalobos F.; Trifiro G.; Sturkenboom M.; Moretti U.; Bellitto C.; Ciccimarra F.; Gonella L.A.; Arzenton E.; Chiamulera C.; Lora R.; Bellantuono D.; Sabaini A.; Firenze A.; Zodda D.; Guidotti F.; Zappone M.; Alagna B.; Cutroneo P.M.; Minore C.; Costantino C.; Vitale F.; D'Alessandro G.; Morreale I.; Marsala L.; Farinella D.; Bavetta S.; Fantini M.P.; Reno C.; Raschi E.; Poluzzi E.; Sapigni E.; Potenza A.M.; Podetti D.; Nikitina V.; Ricciardelli R.; Mogheiseh N.; Croce S.; Paltrinieri B.; Castellani S.; Sangiorgi E.; Selleri M.; Lucchesi S.; Catucci G.; Savini D.; Sacripanti C.; Faccioli M.; Romio M.S.; Rossi L.; Radici S.; Negri G.; Fares L.; Ajolfi C.; Fadda A.; Chiarello A.; Pieraccini F.; Gavioli B.; Palazzi S.; Tuccori M.; Vannacci A.; Bonaiuti R.; Ravaldi C.; Lombardi N.; Crescioli G.; Gori F.; Tessari R.; Zandona E.; Zanoni G.; Senna G.; Crivellaro M.A.; Cancian M.; Venturini F.; Ferri M.; Leonardi L.; Orzetti S.; Caccin E.; Baldo P.; Capuano A.; Rafaniello C.; Ferrajolo C.; Pagliaro C.; Mercaldo M.; di Giorgio A.; Tari M.; Manna S.; Farina G.; Di Mauro C.; De Carlo I.; Senesi I.; Pileggi C.; Palleria C.; Gallelli L.; De Sarro G.; de Sarro C.; Verduci C.; Papadopoli R.; Trabace L.; Morgese M.; Schiavone S.; Tucci P.; Bove M.; Lapi F.; Cricelli C.; Racagni G.; Tonolo S.; Fava G.; Giuffrida S.; Amato V.; Gambera M.; Montresor V.; Mastropasqua D. 2023-01-01 DRUG SAFETY - 1.01 Articolo in rivista Safety of COVID-19 Vaccines Among the Paediatric Population Analysis of the European Surveillance Systems and Pivotal Clinical Trials.pdf
Spotlight commentary: The value of spontaneous reporting systems to detect (the lack of) clinically relevant drug–drug interactions in clinical practice Raschi, Emanuel; Poluzzi, Elisabetta; De Ponti, Fabrizio 2023-01-01 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY - 1.04 Replica / breve intervento (e simili) -
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies Giunchi V.; Fusaroli M.; Linder E.; Villén J.; Wettermark B.; Nekoro M.; Raschi E.; Lunghi C.; Po...luzzi E. 2023-01-01 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY - 1.01 Articolo in rivista Brit J Clinical Pharma - 2023 - Giunchi - The environmental impact of pharmaceuticals in Italy Integrating healthcare and.pdf15761.zip
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System Raschi E.; Fusaroli M.; Giunchi V.; Repaci A.; Pelusi C.; Mollica V.; Massari F.; Ardizzoni A.; P...oluzzi E.; Pagotto U.; Di Dalmazi G. 2022-01-01 CANCERS - 1.01 Articolo in rivista cancers-14-04610-v2 (2).pdf
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Gaimari A.; Fusaroli M.; Raschi E.; Baldin E.; Vignatelli L.; Nonino F.; De Ponti F.; Mandrioli J....; Poluzzi E. 2022-01-01 DRUG SAFETY - 1.01 Articolo in rivista Amyotrophic.pdf
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study Selke Krulichova I.; Selke G.W.; Bennie M.; Hajiebrahimi M.; Nyberg F.; Furst J.; Garuoliene K.; ...Poluzzi E.; Slaby J.; Yahni C.Z.; Altini M.; Fantini M.P.; Koci V.; McTaggart S.; Pontes C.; Reno C.; Rosa S.; Pedrola M.T.; Udovic M.; Wettermark B. 2022-01-01 PHARMACOEPIDEMIOLOGY AND DRUG SAFETY - 1.01 Articolo in rivista Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study.pdfpds5509-sup-0001-supinfo.pdf
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems Gatti M.; Fusaroli M.; Raschi E.; Capelli I.; Poluzzi E.; De Ponti F. 2022-01-01 JN. JOURNAL OF NEPHROLOGY - 1.01 Articolo in rivista 40620_2021_1191_MOESM2_ESM.pptx40620_2021_1191_MOESM1_ESM.pptx